First Clinical Report on the Treatment of Parkinson's Disease with Fetal Midbrain Precursor Cells.

Joopyoung Kim,Han Inbo,Hyun Sook Kim,WonChan Kim,Su Jin Jang,Kyunghoon Min,Sang Heum Kim,Sang‐Hun Bae,Yun‐Hwa Jeong,Borah Kim,Chul Kim,Sigrid C. Schwarz,Johannes Schwarz,Kyung Gi Cho,Sang‐Sup Chung,Jisook Moon

Movement disorders : official journal of the Movement Disorder Society（2023）

引用 1|浏览10

暂无评分

摘要

Our results primarily demonstrate the safety and plausible dose-dependent efficacy of human fetal midbrain-derived dopamine neuronal precursor cells for idiopathic Parkinson's disease. © 2023 International Parkinson and Movement Disorder Society.

查看译文

关键词

Parkinson's disease,clinical trial,efficacy,human fetal mesencephalic dopamine neural precursor cells,safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要